| pubmed-article:19443352 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19443352 | lifeskim:mentions | umls-concept:C0021344 | lld:lifeskim |
| pubmed-article:19443352 | lifeskim:mentions | umls-concept:C0950124 | lld:lifeskim |
| pubmed-article:19443352 | lifeskim:mentions | umls-concept:C0280313 | lld:lifeskim |
| pubmed-article:19443352 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:19443352 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:19443352 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:19443352 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:19443352 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19443352 | pubmed:dateCreated | 2009-5-15 | lld:pubmed |
| pubmed-article:19443352 | pubmed:abstractText | The aim of this study was to determine the presence of high-risk HPV-16 in patients with HNSCC, assess the impact of HPV status on treatment response and survival in this select cohort treated with combined modality therapy and to identify the differences in HIF-1alpha and VEGF expression in HPV-positive and -negative tumors. | lld:pubmed |
| pubmed-article:19443352 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19443352 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19443352 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19443352 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19443352 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19443352 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19443352 | pubmed:month | May | lld:pubmed |
| pubmed-article:19443352 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:DickM FMF | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:LiuXiyongX | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:SomloGeorgeG | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:JoSolomonS | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:WilczynskiSha... | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:JOBJ CJC | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:ShibataStephe... | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:VoraNayanaN | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:JuhaszAgnesA | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:PazBenjaminB | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:ZhangKeqiangK | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:RuelChristoph... | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:LoeraSofiaS | lld:pubmed |
| pubmed-article:19443352 | pubmed:author | pubmed-author:EllenhornJosh... | lld:pubmed |
| pubmed-article:19443352 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19443352 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:19443352 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19443352 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19443352 | pubmed:pagination | 1467-74 | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:meshHeading | pubmed-meshheading:19443352... | lld:pubmed |
| pubmed-article:19443352 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19443352 | pubmed:articleTitle | Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. | lld:pubmed |
| pubmed-article:19443352 | pubmed:affiliation | City of Hope National Medical Center, 1500 East Duarte Rd, Duarte, CA 91010, U.S.A. | lld:pubmed |
| pubmed-article:19443352 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19443352 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19443352 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:19443352 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19443352 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19443352 | lld:pubmed |
